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Background: Diabetic kidney disease, a global health issue, remains associated with high morbidity and mortality.
Previous research has shown that multidisciplinary management of chronic disease can improve patient outcomes.
The effect of multidisciplinary self-care management on quality of life and renal function of patients with diabetic
kidney disease has not yet been well established.
Method/Design: The aim of this study is to evaluate the impact of a multidisciplinary self-care management program
on quality of life, self-care behavior, adherence to anti-hypertensive treatment, glycemic control, and renal function of
adults with diabetic kidney disease. A uniform balanced cross-over design is used, with the objective to recruit 40 adult
participants with diabetic kidney disease, from public and private out-patient settings in French speaking Switzerland.
Participants are randomized in equal number into four study arms. Each participant receives usual care alternating with
the multidisciplinary self- care management program. Each treatment period lasts three months and is repeated twice at
different time intervals over 12 months depending on the cross-over arm. The multidisciplinary self-care management
program is led by an advanced practice nurse and adds nursing and dietary consultations and follow-ups, to the habitual
management provided by the general practitioner, the nephrologist and the diabetologist. Data is collected
every three months for 12 months. Quality of life is measured using the Audit of Diabetes-Dependent Quality of
Life scale, patient self-care behavior is assessed using the Revised Summary of Diabetes Self-Care Activities, and
adherence to anti-hypertensive therapy is evaluated using the Medication Events Monitoring System. Blood
glucose control is measured by the glycated hemoglobin levels and renal function by serum creatinine, estimated
glomerular filtration rate and urinary albumin/creatinine ratio. Data will be analyzed using STATA version 14.
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Discussion: The cross-over design will elucidate the responses of individual participant to each treatment, and will
allow us to better evaluate the use of such a design in clinical settings and behavioral studies. This study also explores
the impact of a theory-based nursing practice and its implementation into a multidisciplinary context.
Trial registration: ClinicalTrials.gov identifier: NCT01967901, registered on the 18th of October 2013.
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Diabetic Kidney Disease (DKD) is becoming a global health
concern [1] that affects largely the elderly population [2].
Despite advances in pharmacology and management
strategies, it remains associated with high morbidity and
mortality [3]. Non-adherence to the treatment regimen is
thought to be the major cause for the poor control and the
complications in these patients [4]. Multidisciplinary
management of chronic disease has been shown to improve
patient outcomes [5]. Up to our knowledge, few studies
addressed specifically the multidisciplinary management of
DKD and none evaluated the effect of multidisciplinary
self-care management on renal function. A multidisciplin-
ary self-care management program (MSMP) could optimize
self-care, and improve the outcomes of patients with DKD.
DKD affects approximately 30 to 40 % of diabetic
patients [6, 7]. It is a progressive disease associated
with multiple co-morbidities, major complications and
increased health costs. Its main complications include
renal failure, and cardiovascular complications [8]. The
frequent hospitalizations associated with the progression
of the disease and dialysis increase considerably the health
care costs [9]. Further, decreased kidney function was
found to be associated with a highly compromised health
related quality of life [10]. The management of DKD aims
at improving patient outcomes such as functional status,
and quality of life [11], preventing the progression of kid-
ney disease and cardiovascular complications [7]. Patients,
with multiple chronic diseases, like DKD, living at home,
are expected, on daily basis, to fulfill their own self-care
activities [12]. Patients are in general unable to accomplish
their self-care effectively without assistance and guidance
for acquiring symptom monitoring and interpretation
skills, setting priorities and decision making [13]. Accord-
ing to a meta-analysis, chronic disease self-management
programs have shown to improve patients’ clinical out-
comes, like glycemic control [14]. A recent meta-analysis
documented that diabetes mellitus self-management
programs may improve the patients quality of life [15].
The use of multidisciplinary management of chronic kidney
disease (CKD), have been recommended starting at an early
stage of the disease [16]. Several systematic reviews of
the literature or meta-analysis confirm the effectiveness
of multidisciplinary clinic based nurse-led management
programs, multidisciplinary home visit managementprograms, and multidisciplinary home tele-management
programs of various chronic diseases, such as heart failure,
diabetes, and kidney disease, in improving one or more
patient outcomes such as reducing costs, re-hospitalization
rates and mortality, increasing health literacy, and adher-
ence to treatment, ameliorating patients functional status,
self- care abilities and quality of life [11, 17–23]. Few of the
multidisciplinary chronic disease trials used strategies
to improve patient self-care as their primary intervention
[24–30]. These studies addressed mainly heart failure
patients and did not include home visits in their interven-
tion. One study addressed self-management strategies in
the multidisciplinary management of DKD [31]. However,
this study did not evaluate the effect of the intervention
on kidney function, did not investigate a role for an
advanced practice nurse (APN), and did not include home
visits. Considering the constant and predicted increase in
the aging population, the increasing prevalence of DKD,
its clinical significance, and its impact on the daily life of
patients and on the health care system, a MSMP is a
promising approach for improving patients’ outcomes and
stabilizing the kidney function.
Methods/Design
Study aim
The present study is designed to evaluate the impact of a
MSMP on quality of life, self-care behavior, adherence to
anti-hypertensive treatment, glycemic control, and renal
function in adults with DKD. The study protocol adheres
to the SPIRIT reporting guidelines. A SPIRIT checklist is
provided as an additional file (Additional file 1).
The research hypotheses are as follows:
1. The participants with DKD enrolled in the MSMP
demonstrate a significant improvement in their
quality of life, self-care behavior, adherence to anti-
hypertensive therapy, glycemic control, and renal
function as compared to the usual standard care.
2. A high self-care behavior is associated with a high
quality of life and an improved glycemic control.
Study design and setting
The study is using a uniform and strongly balanced
cross-over design. The cross-over design is recommended
for an efficient comparison of treatments when recruiting
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istical power or precision as a randomized controlled trial.
It is for use more importantly in chronic disease where
treatment aims at slowing the progression of the disease,
improving quality of life and preventing complications.
Thus, the patient responses to each treatment are then
compared [32], because in cross-over design, each partici-
pant will receive the treatment and serve as his own con-
trol. Further, a review of randomized control trial (RCT)
interventions designed to improve outcomes of patients
with multi-morbidity showed that interventions had
mixed effects. Patients with chronic diseases enrolled
in the RCTs present heterogeneity of co-morbidities,
therefore comparisons between two groups of patients
seem to be difficult [33]. The strongly balanced and
uniform design represents the ideal cross-over design
that is able to overcome the statistical bias of the first
order carry-over effect and minimize that of the second
order [32]. In the present study, we considered the ef-
fect of the second order carry-over to be negligible.
Each participant is receiving the standard usual care
(UC) and the MSMP at different time periods during
the course of the trial, as described in Table 1 on
“Cross-over plan of participants enrolled in the MSMP
study”. This design will allow us to determine the ef-
fectiveness of an intensive multidisciplinary follow-up
as compared to the standard usual follow-up. The study
is being conducted in public and private out-patient
settings in the French speaking part of Switzerland.
Patients are followed up in the nephrology out-patient
service of the public teaching hospital, namely the
Centre Hospitalier Universitaire Vaudois (CHUV), in
the diabetology out-patient service of a private med-
ical center, namely Clinique La Source, and in private
practice.Study intervention
Patients who have accepted to participate are enrolled in
the study for 12 months. Each participant receives UC
twice over three months at different time intervals, depend-
ing on the cross-over sequence he or she was assigned to.
In addition, each participant receives the MSMP twice over
three months at different time intervals. Therefore, par-





Sequence ABBA (n = 10) A = UC B =
Sequence BAAB (n = 10) B = MSMP A
Sequence AABB (n = 10) A = UC A
Sequence BBAA (n = 10) B = MSMP B =three times as described in Table 1 on “Cross-over plan
of participants enrolled in MSMP study”.
Usual care period-UC
During this period, participants receive the UC man-
agement that consists of a follow-up by their general
practitioner, nephrologist and/or diabetologist. The
participants continue to visit their nephrologist every
three months, on average. Other healthcare professionals
such as a pharmacist, a physiotherapist, a podiatrist, a
psychologist, and a social worker may be consulted as
needed. Depending on previous hospitalizations or on
earlier referrals made by their general practitioner, or
diabetologist, participants might have been exposed,
prior to the commencement of the study to diabetes
education and, or dietary intervention. However, we assume
that they have not been exposed to self-care management
programs because the self-care management approach of
the current study is a pioneer one in the French speaking
part of Switzerland.
The multidisciplinary self-care management program
period- MSMP
During this period, participants continue to see their
general practitioner, usual nephrologist and/or diabetol-
ogist. In addition, they receive multidisciplinary care, led
and coordinated by an APN. The MSMP care consists of
nursing care by a nurse specialized in diabetes care from
the out-patient service of a private medical center, namely
the Clinique La Source and follow-ups by a private prac-
tice dietician. A diabetes specialized nurse is delivering the
main nursing intervention because most of the patients’
expected daily self-care activities are related to diabetes
management and a nursing knowledge and an expertise in
this area is essential for a successful follow-up. Patients
who were not followed-up by a diabetologist prior to their
enrollment in the study, are systematically referred to a
diabetologist resident in the CHUV for one basic consult-
ation. The diabetes specialized nurse and the dietician,
adopt as recommended, a self-care management approach
that is patient-centered responding to patients’ prefer-
ences, needs and values, supporting patients in informed
decision-making, and developing problem-solving skills
[34]. The program consists of two dietary consultations,






MSMP B =MSMP A = UC
= UC A = UC B =MSMP
= UC B =MSMP B =MSMP
MSMP A = UC A = UC
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under the supervision of the study diabetologist. Partici-
pants receive a follow-up every two weeks, by one of the
MSMP healthcare member, that is the diabetes specialized
nurse, a dietician, a nephrologist or a diabetologist.
This frequency was adopted based on the results of a
retrospective cohort of patients with diabetes mellitus
(n = 26,496) that evaluated the effective frequency of
contact with a physician that would help achieve the
targeted patient clinical outcomes such as glycemic
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hypoglycemia
3. Counseling on self-care
development
4. Guiding & support X
5. Coordination of Care X X X











Quality of life X




Resource utilization Xwith a consultation with the nurse who completes a
comprehensive initial assessment and shares it with the
multidisciplinary team. An example of the schedule, the
description and the evaluation of a MSMP sequence is
presented in Table 2 on “The schedule, description and
evaluation of the MSMP sequence-BAAB for patients
with DKD”. Each nursing consultation takes about one
hour, except for the initial consultation that lasts for
about one and a half hours. Each nursing telephone
follow-up takes about fifteen minutes. At the end of the
study each participant would have received at least sixence-BAAB for patients with DKD
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follow-ups, and four face to face dietary follow-ups
amounting to a grand total of eleven and a half hours.The role of the advanced practice nurse- APN
In this MSMP, an APN manages the program and en-
sures the coordination of care within the program and
among the public and the private sector. This person is
a nurse and a PhD nursing candidate. The APN role has
been fashioned based on Hamric et al. [36]. The APN is
based in the CHUV nephrology service. She coordinates
the consultations of the dietician and the diabetes spe-
cialized nurse. She provides guidance to the diabetes
specialized nurse and the dietician, assisting them in tai-
loring care based on evidenced-based intervention and
safeguarding a self-care management approach. She dis-
cusses each participants care plan and goals with the
diabetes specialized nurse before and after each consult-
ation. In addition, the APN discusses each care plan and
patient progress with the study diabetologist and the
participant’s nephrologists. Both of these specialty physi-
cians may discuss patient management with the general
practitioner and recommend changes in the medication
regimen. The APN also coordinates the participant care
with other healthcare professionals such as pharmacists,
physiotherapists, and social workers, as needed. Due to
the dispersion of the multidisciplinary team between
public and private sectors, and in order to facilitate the
communication flow and ensure timely sharing of partici-
pants care information, needs and progress, an electronic
application was developed. This application aimed at
sending, directly, the specific assessment and follow-up
forms filled by the diabetes specialized nurse to the APN
and/or the dietician. Due to this immediate sharing of in-
formation, the APN is constantly informed and updated
on patient care and the diabetes specialized nurse’s com-
prehensive assessment is available to the dieticians before
her first encounter with the participant. In addition, the
APN is responsible for the efficacy of the study, its data
collection, and management.The role of the study diabetologist
The multidisciplinary team benefits of a diabetologist
who acts as a consultant for the study. This person is a
DKD specialist and holds a joint position both in the
Service of Diabetes and Endocrinology, and the Service
of Nephrology of the CHUV. During the study, she con-
stantly discusses the participants care plan with the APN,
as well as with the diabetes specialized nurse and the
dietician when necessary. She also discusses partici-
pants’ care plan with the respective nephrologist and
may recommend a change in the patient’s diabetic med-
ications or antihypertensive regimen.The role of the diabetes specialized nurse
Orem’s Self-Care Deficit Theory as described in the
section entitled “the science of the development and
exercise of self-care agency” [37], was used to inform
the diabetes specialized nurse’s role. Specific evidence-
based practice nursing assessment and follow-up forms
and educational materials were identified and adapted
to the purpose of the study and its specific patient
population. All of these forms and materials were trans-
lated into French, and approved by the study team. In
the MSMP, the diabetes specialized nurse institutes a
self-care program. Her role consists of providing a
comprehensive initial clinical and psychosocial assess-
ment of the participant, an evaluation of the participant
medication safety use, and the development of a care
plan collaboratively with the participant who will iden-
tify a priority treatment goal. The participant rates his
or her confidence of potentially attaining the goal and
sign a contract with the diabetes specialized nurse. The
diabetes specialized nurse then develops nursing
interventions that will help the participant meet the
goal. Nursing interventions include tailored teaching,
counseling and support. All participants receive evi-
denced based educational material on how to best pro-
tect their kidneys, that was conceived for the purpose
of the study. Participants are asked to contact the dia-
betes specialized nurse during working hours for any
question related to the MSMP and the emergency de-
partment of the CHUV outside working hours.The role of the dietician
All participants are screened and evaluated by one of the
two dieticians of the study. Each receives an individualized
dietary care plan. Subsequently, the dietician may recom-
mend to the diabetes specialized nurse to reinforce dietary
teaching during nursing follow-ups. The dietician
documents the participant’s dietary goal, summarizes
the follow-up and communicates it to the diabetes
specialized nurse and the APN. The dietician provides
the patients with teaching and evidenced based dietary
pamphlets developed by the local dietetic association on
hyper- and hypoglycemia management, moderate salt diet,
potassium content in foods and healthy protein intake.Identification of eligible patients
Patients are recruited with the help of the nephrologists
of the CHUV out-patients Nephrology Service and dia-
betologists in one mid-size town of the French speaking
part of Switzerland, according to the inclusion and
exclusion criteria described in Table 3 on “Inclusion and
exclusion criteria”. The physicians give patients detailed
information on the study and are available along with
the APN to answer patients’ questions.
Table 3 Inclusion and exclusion criteria
Inclusion criteria
1. Age 18 and over.
2. Clinical diagnosis of diabetes.
3. Clinical diagnosis of renal disease and an estimated glomerular
filtration rate (eGFR) of less than 60 ml/min calculated based on
the CKD Epidemiology Collaboration (CKD_EPI) formula and/or
an Albumin/Creatinine ratio of 30 mg/mmol or more.
4. Free of cognitive deficit as assessed by the recruiting physician, based
on a normal score on the French version of the Short Portable Mental
Status Questionnaire [45]. In the case of a patient being diagnosed
with a cognitive deficit, the physician ensures patient’ referral or
follow-up.
5. Free of psychomotor skills limitations as determined by the recruiting
physician based on the physical examination of the patient.
6. Able to read, write and speak in French.
7. Signed informed consent.
Exclusion criteria
1. Terminal illness other than CKD such as cancer or severe heart failure.
2. Planned major surgical procedures.
3. Patient on dialysis.
4. Patient receiving nursing home care visits for the management of
diabetes.
Table 4 Overview of the MSMP study outcome variables
Dependent variables Dimension (s) measured Measure used
Patient Variables
Quality of Life Present Quality of Life ADDQoL
Impact of Diabetes on
Quality of Life
ADDQoL
Impact of Diabetes on Life
Domains
ADDQoL
Self-Care Behavior Diet Habits R-SDSCA
Exercise Habits R-SDSCA







Blood Glucose control HbA1c %







The MSMP use outside
the defined frequency of
the intervention
The number of times the
participant seek help from
the MSMP outside the
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The recruiting diabetologists and nephrologists are blinded
to the allocation sequence. The allocation sequence was
generated by a computer random number generator,
allowing equal numbers of patients in the, study four
arms, referred to as sequences of follow-up, as shown in
Table 1 on “Cross-over plan of participants enrolled in the
MSMP study”. Patients who have accepted to participate
and signed the written consent, are referred by the recruit-
ing physician to the APN who assigns them chronologically
according to the allocation sequence. After patients are
assigned to a sequence, the patients and healthcare pro-
viders are no more blinded to the intervention sequence.
Primary outcome
The primary outcome of the study is quality of life. It is
measured using the French version of the Audit of
Diabetes-Dependent Quality of life (ADDQoL) measure.
The ADDQoL is a self-administered questionnaire con-
stituted of 19 items covering the present quality of life,
the impact of diabetes on quality of life, the impact of
diabetes on life domains mainly the social life, the phys-
ical health, the self-confidence, the motivation feelings
about the future, the dependency on others, the living
conditions and others (Cronbach α coefficient = 0.947) [38].
Secondary outcomes
The secondary outcomes, described in Table 4 on the
“Overview of the MSMP study outcome variables”, are
self-care behavior including adherence to anti-hypertensivetreatment, and clinical outcomes, including blood glucose
control and renal function. Demographic and clinical data
are also collected from participants’ records and interviews
using a demographic data questionnaire. The MSMP use
outside the defined frequency of the intervention is also
assessed. Secondary outcomes are measured as follows:
1. Patient self-care behavior using the French version
of the Revised Summary of Diabetes Self-Care
Activities (R-SDSCA) which is a self-administered
questionnaire, constituted of 10 items covering
dietary habits, physical activity, blood glucose
monitoring, foot care, and smoking (mean
inter-item = 0.47; except for diet mean
inter-item = 0.40) [39].
2. Adherence to anti-hypertensive therapy using the
Medication Events Monitoring System (MEMS)
[40], throughout the study.
3. Blood glucose control through the measurement of
glycated hemoglobin (HbA1c).
4. Kidney function through the measurement of serum
creatinine, eGFR using CKD_EPI formula and
urinary albumin/creatinine ratio.
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through the calculation of the number of times
participants seek help from the MSMP team outside
the defined frequency.
Data collection and management
Participants are enrolled in the study for 12 months.
Measurements are carried out after each follow-up period.
A total of four measurement times are required; at base-
line (T0), at the end of three months of follow-up (T1), at
the end of six months of follow-up (T2), at the end of nine
months of follow-up (T3) and at the end of 12 months of
follow-up (T4).
The laboratory carrying out the analyses of the blood
and urine sample is blinded to the study protocol and
patient allocation sequence. The self-administered ques-
tionnaires are posted to the patient with return envelops
or given to the patient to answer while waiting for his
appointment with the physician. Reminder letters are sent
to patients who fail to respond to the self-administered
questionnaires within a week. Data collection is organized
and managed by the APN. Laboratory results are entered by
the blinded laboratory personnel and double checked by the
APN. Results of the self-administered questionnaire are en-
tered by the APN and overseen by a computer assistant,
who is blinded to the patient sequence allocation. The statis-
tician carrying out the data analysis is independent from the
study and blinded to the patient allocation sequence.
In order to promote participant retention, the recruiting
physician, discusses the study with the patient every
three months during the regular follow-up. Also, the study
is designed with home visits that would facilitate participa-
tion of the patients and thus contributing to study retention.
Statistical analysis
The data will be analyzed, with intent to treat concept,
using SPSS for Windows version 22. Data will be
expressed as means ± Standard deviation of the mean,
and a p-value of less than 0.05 will be considered statis-
tically significant. Statistics that account for the fact that
participants serve as their own control will be performed
to detect the changes in variables at each follow-up
period. Pearson’s product correlation test will be used to
detect possible correlations among variables.
Data monitoring
Data is monitored by the ethics committee who requires
adverse events reporting, in addition to a yearly interim
reporting on the progress of the study, the processes,
and the number of drop-outs.
Safety assessments
The investigators assume that there will be no risk associ-
ated with the study and participants’ psychological andbiological integrity will be preserved. Nonetheless, an insti-
tutional insurance is obtained from the CHUV. As soon as
participants are enrolled in the study, the general practi-
tioner is informed. The study adds an intensive follow-up
by a multidisciplinary team and does not alter or interfere
with follow-up visits of the general practitioner who con-
tinue the participant’s care as planned. At the end of the
study, the multidisciplinary team will remain available for
follow-up if desired by the general practitioner. The study
diabetologist oversees the care plans, ensures participants’
surveillance and will terminate participation if changes in
clinical conditions emerge and the participant falls under
one or more of the study exclusion criteria.
Efficacy assessments
In order for the nurse’s role to be possible, clinical reason-
ing skills need to be present, hence, a nurse with 20 years
of experience in the field of diabetes care was recruited to
the study. Also, the recruited diabetes specialized nurse be-
lieves in the intervention, the importance of fostering self-
care, and is confident in being able to execute the nursing
role as required by the protocol. The diabetes specialized
nurse follows up all patients included in the study and
throughout the whole study period. To ensure efficacy and
internal consistency, care was structured by using elec-
tronic forms for data entry on patient assessment and
follow-up. All the specific assessment forms and follow-up
forms were transformed into electronic questionnaires.
Hence, few questions, relevant to the patient assessment,
are mandatory in order to proceed to the following
questions. Rendering questions mandatory ensures com-
pleteness of the comprehensive patient assessment, with-
out missing information. All the verbal communications
within the multidisciplinary team is also documented elec-
tronically. Each patient signs with the diabetes specialized
nurse, a contract describing his or her priority goal. The
contract includes a description of the barriers and the plan
for attaining the goal.
Power calculation
Patients’ quality of life is our main outcome. Multiple
chronic diseases are associated with compromised quality
of life [41]. Our patient population suffers from two
chronic conditions, i.e., diabetes and kidney disease. Qual-
ity of life degrades with the continuous decline of the
kidney function [42]. However, improvement of patients’
quality of life is one of the main goals of the management
of DKD [11]. A recent meta-analysis documented that dia-
betes self-management programs may improve patients’
quality of life [15] and the American Diabetes Association
[34] recommends the measurements of quality of life as an
endpoint in diabetes self-care management programs. Con-
sidering quality of life as measured by the ADDQoL in pa-
tients with complications [43] as the primary outcome for
Helou et al. BMC Nephrology  (2016) 17:88 Page 8 of 10the estimation of a statistical power and a 20 % improve-
ment on the ADDQoL as clinically significant, at an α of
0.05 & a power of 0.08 for powered statistical tests of sig-
nificance and the variance for all variables, 32 patients are
required to detect a 20 % absolute difference with three
months intervals. To compensate for a 20 % expected
drop-out rate, a total number of 40 participants is
required.
Estimated timeline
The expected study duration is 36 months.
Confidentiality and data security
Participants’ privacy is respected. Results and personal
information are kept confidential. Only the investigators
have access to the participants’ data which is coded to
ensure confidentiality.
Retribution
No compensation or retribution for participation in the
study is offered. However, the cost of the transportation
to the diabetes specialized nurse and the dietician private
practice are reimbursed. Blood tests including serum
creatinine, eGFR, urinary albumin/creatinine ratio and
HbA1c are charged on the study expenses.
Discussion
Results of the study will show whether a MSMP for
patients with DKD improves quality of life and delay the
progression of the disease by preserving the kidney func-
tion, through optimization of the patient adherence to
anti-hypertensive treatment, development of self-care
abilities and achievement of an optimal glycemic control.
Few studies have employed an experimental prospective
design to evaluate multidisciplinary management in
DKD to date. Therefore, to elucidate the effect of a
multidisciplinary management of DKD, randomized trials
are needed. The present study offers to patients with DKD
at an early stage of the disease, a six months individualized
patient care as part of a multidisciplinary self-care
management including clinic and home nursing visits.
A balanced cross-over design is used in this study. This
design has rarely been used in behavioral and nursing
studies. However, cross-over designs are recommended
for understanding each patient’s response to different
treatments. Thus, it will be possible to better evaluate
the efficacy of such designs in clinical settings and behav-
ioral studies. Recruitment from the DKD population is
challenging as this population presents multi-morbidities.
Adding nursing visits, home visits, dietary visits and tele-
phone follow-ups at a frequency of one every two weeks,
is constraining to some patients.
One of the study limitations can be attributed to the
role of APN. She delivers the coordination of care as partof the study MSMP intervention and is directly involved
in outcome data organization. She is overseeing data
collection when not blinded to treatment allocation.
However, outcomes measurements were carried out by
the participant himself for the self-reported question-
naire and by an independent laboratory for the clinical
outcomes. These measures prohibited the APN from
influencing data collection directly.
This study will shed the light on an advanced role for
nurses in Switzerland. It is also evaluating the impact of
integrating a theory based nursing role into practice. The
roles of the APN, the diabetes specialized nurse, and the
flow of the coordination among all team-members is de-
signed in a way that meets the dynamics of the Swiss
healthcare system, while at the same time introducing a
new role for nurses. In addition to the usual medically
delegated tasks, the nurse has the opportunity to exercise
her critical thinking and demonstrate her role in the
multidisciplinary team through her assessment, compe-
tencies in patient follow-up and coordination of care.
One strength of this study is the fostering of collaboration
between the public and the private sector in Switzerland.
However, this collaboration adds a major challenge to pa-
tient care coordination. This is due to the fact that the
multidisciplinary team in this study is not based at the
same place. Some team members are working in the pub-
lic sector, some others in the private sector and at differ-
ing locations. Therefore, the multidisciplinary team
collaboration is “virtual” and proper communication is es-
sential to make up for the lack of a physical setting for en-
counters and constant exchange. To improve
coordination of participants’ visits to different healthcare
professionals, the appointments with the dieticians and
the diabetes specialized nurse were centralized with the
APN. As each of these providers had other patients
outside the study to look after, coordination of ap-
pointment may present as a limitation. When partici-
pants miss an appointment, rescheduling becomes
constraining and much exchanging is necessary in
order to achieve a successful rescheduling. In an ex-
ploratory study, using focus groups with patients with
type 2 diabetes mellitus, the lack of individualized
and coordinated care were the most often reported
perceived barriers to effective implementation of self-
care plans [44]. Beyond these difficulties, results of
this study will highlight the importance of a multidis-
ciplinary care with self-care management as a primary
goal, for ensuring an individualized collaborative
approach, in which the patient plays a major role.Additional file
Additional file 1: SPIRIT Checklist. (DOC 123 kb)
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